Momcort (Mometasone Furoate)

Mometasone furoate, the active ingredient in Momcort, is a corticosteroid presented as a nasal spray for nasal administration. It is indicated for the relief of nasal symptoms associated with allergic rhinitis in both adults and pediatric patients, reducing inflammation and congestion.

GNH USA supplies Momcort as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing consistent quality and regulatory compliance for global distribution. The product complies with European Union marketing authorisation standards and is manufactured under GMP conditions.

Momcort (mometasone furoate) is a nasal corticosteroid used to manage inflammatory conditions of the nasal passages. - Allergic rhinitis: reduces nasal congestion, itching, and sneezing. - Seasonal allergic rhinitis: provides symptom relief during pollen exposure. - Perennial allergic rhinitis: controls year‑round nasal inflammation.

Mometasone furoate nasal spray may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning. - Headache. - Epistaxis (nosebleed). - Sore throat. - Altered taste. - Cough.

Serious or Rare Side Effects: - Nasal septal perforation. - Adrenal suppression. - Cataracts or increased intra‑ocular pressure. - Severe allergic reaction (anaphylaxis). - Opportunistic fungal infection of the nasal passages.

Before prescribing Momcort, clinicians should consider several precautionary measures to ensure safe use. - Assess for nasal infections: avoid use in active bacterial, fungal, or viral sinusitis. - Monitor in patients with glaucoma or cataracts: may exacerbate intra‑ocular pressure. - Caution in children: use the lowest effective dose and limit duration. - Evaluate systemic corticosteroid exposure: avoid concurrent high‑dose systemic steroids. - Avoid abrupt discontinuation: taper if long‑term therapy is required. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Mometasone furoate nasal spray can interact with certain medications, affecting either its efficacy or safety profile.

Major Interactions (Avoid): - Concomitant strong CYP3A4 inhibitors may increase systemic exposure. - Use with systemic corticosteroids can lead to additive immunosuppression. - Concurrent immunosuppressants may raise the risk of infection.

Moderate Interactions (Monitor Closely): - Intranasal decongestants may increase local irritation. - Antihistamines can mask symptoms, potentially delaying detection of adverse effects.